Multivalent, Stabilized Mannose‐6‐Phosphates for the Targeted Delivery of Toll‐Like Receptor Ligands and Peptide Antigens

Niels R. M. Reintjens,Elena Tondini,Christopher Vis,Toroa McGlinn,Nico J. Meeuwenoord,Tim P. Hogervorst,Herman S. Overkleeft,Dmitri V. Filippov,Gijsbert A. Marel,Ferry Ossendorp,Jeroen D. C. Codée

DOI: https://doi.org/10.1002/cbic.202000538

IF: 3.2

2020-10-23

ChemBioChem

Abstract:Mannose‐6‐phosphate (M6P) is recognized by the mannose‐6‐phosphate receptor and plays an important role in the transport of cargo to the endosomes, making it an attractive tool to improve endosomal trafficking of vaccines. We here describe the assembly of peptide antigen conjugates carrying clusters of mannose‐6‐C‐phosphonates (M6Po). The M6Po's represent stable M6P mimics that are resistant to cleavage of the phosphate group by endogenous phosphatases. Two different strategies for the incorporation of the M6Po clusters in the conjugate have been developed: the first relying on a "post‐assembly" click approach employing an M6Po bearing an alkyne functionality; the second hinges on an M6Po C‐glycoside amino acid building block that can be used in solid‐phase peptide synthesis. The generated conjugates were further equipped with a TLR7‐ligand to stimulate dendritic cell (DC) maturation. While antigen presentation is hindered by the presence of the M6Po clusters, the incorporation of the M6Po clusters leads to increased activation of DCs, demonstrating their potential in improving vaccine adjuvanticity by intraendosomally active TLR‐ligands.

biochemistry & molecular biology,chemistry, medicinal

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: how to target Toll - like receptor ligands (TLR ligands) and peptide antigens to immune cells by designing and synthesizing stable multivalent mannose - 6 - phosphate analogs (M6Po), in order to enhance the immunogenicity and adjuvant effect of vaccines.

Specifically, the authors focus on the following aspects:

1. **Overcoming the influence of endogenous phosphatases**: Natural mannose - 6 - phosphate (M6P) is easily hydrolyzed by endogenous phosphatases, thus affecting its effectiveness as a targeting tool. Therefore, researchers have developed more stable C - phosphoryl mannose (M6Po) to avoid this hydrolysis problem.

2. **Improving antigen - presenting efficiency**: By binding M6Po clusters to peptide antigens and using mannose - 6 - phosphate receptor (MPR) - mediated endocytosis, antigens are efficiently delivered to the endosomes of dendritic cells (DCs), thereby activating Toll - like receptors (such as TLR7), promoting DC maturation and enhancing antigen presentation.

3. **Optimizing the immune response**: Researchers hope to verify whether the introduction of TLR7 ligands and M6Po clusters can synergistically enhance DC activation and antigen presentation, thereby improving the overall immune response effect.

To achieve these goals, researchers synthesized two types of peptide - antigen conjugates and evaluated their effects on DC maturation and antigen presentation. The experimental results show that although the presence of M6Po clusters hinders antigen presentation, it significantly enhances DC activation, especially when co - existing with TLR7 ligands. This provides new ideas for the future design of more effective vaccines, especially in cases where an enhanced immune response is required.